These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8188580)

  • 1. Fluctuation analysis of mutations to nalidixic acid resistance in Escherichia coli.
    Boe L; Tolker-Nielsen T; Eegholm KM; Spliid H; Vrang A
    J Bacteriol; 1994 May; 176(10):2781-7. PubMed ID: 8188580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive R plasmid mutator effect on chromosomal mutation to nalidixic acid resistance in nalidixic acid-exposed cultures of Escherichia coli.
    Ambler JE; Pinney RJ
    J Antimicrob Chemother; 1995 May; 35(5):603-9. PubMed ID: 7592173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Types of spontaneous nalidixic acid resistant mutants of Escherichia coli.
    Kumar S
    Indian J Exp Biol; 1980 Apr; 18(4):341-3. PubMed ID: 6995285
    [No Abstract]   [Full Text] [Related]  

  • 4. Elevated mutagenesis does not explain the increased frequency of antibiotic resistant mutants in starved aging colonies.
    Katz S; Hershberg R
    PLoS Genet; 2013 Nov; 9(11):e1003968. PubMed ID: 24244205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation affecting resistance of Escherichia coli K12 to nalidixic acid.
    Hrebenda J; Heleszko H; Brzostek K; Bielecki J
    J Gen Microbiol; 1985 Sep; 131(9):2285-92. PubMed ID: 3906038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nalidixic acid-resistant auxotrophs of Escherichia coli.
    Helling RB; Adams BS
    J Bacteriol; 1970 Nov; 104(2):1027-9. PubMed ID: 4923064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Resistance to nalidixic acid in tetracycline-resistant mutants of E. coli].
    Khanina MF; Gromova TG; Terekhov AA
    Antibiotiki; 1975; 20(12):1099-104. PubMed ID: 773284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo selection during ofloxacin therapy of Escherichia coli with combined topoisomerase mutations that confer high resistance to ofloxacin but susceptibility to nalidixic acid.
    Cattoir V; Lesprit P; Lascols C; Denamur E; Legrand P; Soussy CJ; Cambau E
    J Antimicrob Chemother; 2006 Nov; 58(5):1054-7. PubMed ID: 16984897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of action of nalidixic acid on Escherichia coli. V. Possible mutagenic effect.
    Cook TM; Goss WA; Deitz WH
    Acta Chir Belg; 1966; ():780-3. PubMed ID: 5327371
    [No Abstract]   [Full Text] [Related]  

  • 10. The responses of Escherichia coli to nalidixic acid.
    Greenwood D; O'Grady F
    Chemotherapy; 1978; 24(4):249-58. PubMed ID: 348417
    [No Abstract]   [Full Text] [Related]  

  • 11. Streptomycin and nalidixic acid elevate the spontaneous genome-wide mutation rate in Escherichia coli.
    Ozdemirel HO; Ulusal D; Kucukyildirim Celik S
    Genetica; 2021 Feb; 149(1):73-80. PubMed ID: 33502702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of nalidixic acid on recombination and DNA repair of Escherichia coli K-12 strains.
    Inan S; Kalaycioglu A
    Indian J Exp Biol; 1996 Oct; 34(10):949-53. PubMed ID: 9055644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sensitivity of an E. coli strain during therapy of experimental pyelonephritis using nalidixic acid].
    Hatala M; Ritzerfeld W; Prát V; Konícková L; Losse H
    Cas Lek Cesk; 1970 Mar; 109(14):291-6. PubMed ID: 4909024
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterisation of novel mutations involved in quinolone resistance in Escherichia coli isolated from imported shrimp.
    Nawaz M; Sung K; Kweon O; Khan S; Nawaz S; Steele R
    Int J Antimicrob Agents; 2015 May; 45(5):471-6. PubMed ID: 25631675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo sequential selection of Escherichia coli with topoisomerase- and efflux-mediated misleading quinolone resistance phenotypes.
    Smati M; Emond JP; Arlet G; Tankovic J
    Microb Drug Resist; 2012 Feb; 18(1):19-22. PubMed ID: 22043806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic analysis of the requirements for SOS induction by nalidixic acid in Escherichia coli.
    Newmark KG; O'Reilly EK; Pohlhaus JR; Kreuzer KN
    Gene; 2005 Aug; 356():69-76. PubMed ID: 16005583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [4-Nitroquinoline-1-oxide induced adaptive and cross resistance to ultraviolet rays and nalidixic acid in Enterococcus faecalis].
    Vorob'eva LI; Cherdyntseva TA
    Mikrobiologiia; 1998; 67(4):522-6. PubMed ID: 9785346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New algorithms for Luria-Delbrück fluctuation analysis.
    Zheng Q
    Math Biosci; 2005 Aug; 196(2):198-214. PubMed ID: 15950991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation rate of avian intestinal coliform bacteria when pressured with fluoroquinolones.
    Medders WM; Wooley RE; Gibbs PS; Shotts EB; Brown J
    Avian Dis; 1998; 42(1):146-53. PubMed ID: 9533092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Character of the effect of nalidixic acid (negram) on Escherichia coli strain 613].
    Planel'es KhKh; Andreeva AM; Moroz AF
    Antibiotiki; 1968 Jul; 13(7):617-20. PubMed ID: 4880236
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.